Onglets principaux
Exporter 67 resultats:
Filtres: Auteur is Cyril Barbezange
Weekly flu Bulletin week 03-2024,
, 24-feb-2024, Brussel, (2024)
Genomic monitoring of SARS-CoV-2 variants using sentinel SARI hospital surveillance.,
, Influenza Other Respir Viruses, 2023 Oct, Volume 17, Issue 10, (2023)
Genomic monitoring of SARS‐CoV‐2 variants using sentinel SARI hospital surveillance,
, Influenza and Other Respiratory Viruses, Jan-10-2023, Volume 17, Issue 10, (2023)
Influenza versus other respiratory viruses – assessing severity among hospitalised children, Belgium, 2011 to 2020.,
, Eurosurveillance, Aug-07-2024, Volume 28, Issue 29, (2023)
Influenza-like illness (including COVID-19) sentinel surveillance in Belgian nursing homes: amended protocol - V2,
, 05/09/2023, p.24, (2023)
Risk Factors Associated with Severe RSV Infection in Infants: What Is the Role of Viral Co-Infections?,
, Microbiol Spectr, 2023 Jun 15, Volume 11, Issue 3, (2023)
Surveillance des infections à influenza. Rapport épidémiologique saison 2019-2020,
, 28/07/2023, Bruxelles, Belgique, p.32, (2023)
Surveillance van griepinfecties. Epidemiologische rapport seizoen 2019-2020,
, 28/07/2023, Brussel, België, p.31, (2023)
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.,
, Euro Surveill, 2023 Nov, Volume 28, Issue 47, (2023)
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021,
, Eurosurveillance, 24/11/2023, Volume 28, Issue 47, (2023)
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.,
, Euro Surveill, 2023 Nov, Volume 28, Issue 47, (2023)
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022,
, Eurosurveillance, 24/11/2023, Volume 28, Issue 47, (2023)
Virological surveillance of influenza in Belgium, season 2019-2020,
, 2023, Brussels, Belgium, p.35, (2023)
Virological surveillance report of the NRC influenza for season 2020-2021,
, 2023, Brussels, Belgium, p.24, (2023)
Virological surveillance report of the NRC influenza for season 2022-2023,
, 2023, Brussels, Belgium, p.38, (2023)
Virological surveillance report of the NRC influenza for season 2021-2022,
, 2023, Brussels, Belgium, p.33, (2023)
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial.,
, Int J Infect Dis, 2022 Sep, Volume 122, (2022)
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study.,
, Viruses, 2022 04 28, Volume 14, Issue 5, (2022)
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study,
, Viruses, Jan-05-2022, Volume 14, Issue 5, (2022)
Sentinel SARI surveillance in Belgium in times of COVID-19 pandemic,
, OPTIONS XI for the Control of Influenza, 2022, Belfast, United-Kingdom, (2022)
Was SARI surveillance successful at monitoring SARS-CoV-2 circulation and its genomic evolution in Belgium throughout the pandemic?,
, OPTIONS XI for the Control of Influenza, 2022, Belfast, United-Kingdom, (2022)
Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.,
, Eur Respir J, 2021 Aug 26, (2021)
Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide.,
, Front Immunol, 2021, Volume 12, (2021)
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.,
, Lancet Microbe, 2021 Mar, Volume 2, Issue 3, (2021)